What Researchers Did
Researchers conducted a systematic review and meta-analysis of randomized controlled trials to compare hyperbaric oxygen therapy with other treatments for diabetic foot ulcers, stratified by Wagner grading.
What They Found
Hyperbaric oxygen therapy significantly improved wound healing rates 8 or more weeks post-treatment compared to other therapies (RR = 2.39; 1.87-3.05). Adjunctive hyperbaric oxygen therapy improved wound healing for Wagner grades II, III, and IV, prevented minor amputations for grade III and major amputations for grade IV, and reduced operative debridement in grade II wounds.
What This Means for Canadian Patients
Hyperbaric oxygen therapy could be a valuable adjunctive treatment option for Canadian patients with diabetic foot ulcers, potentially improving wound healing and reducing the need for amputations. Patients with Wagner grade II, III, or IV ulcers might particularly benefit from this therapy to prevent complications like debridement or limb loss.
Canadian Relevance
This study did not include any Canadian participants or data, so its direct relevance to the Canadian healthcare context is not explicitly established.
Study Limitations
A limitation of this meta-analysis is that the evidence for some outcomes was only of moderate quality.